Please login to the form below

The role of empathy in the design of products and services

Peter Timmer of Blue Latitude Health talks through what it means to design with empathy for the customer, and why it produces better products and services.
When you design a product that truly addresses an unmet need, that product will establish an emotional connection with the user, from which engagement becomes real.

How might you gain the insight that will uncover the hierarchy of unmet customer needs, from which you will choose the one your product will address?  

One answer to this question is the development of an empathetic mindset, a mindset that seeks a detailed understanding of the customer and what they feel and think, when doing things at work – things where unmet needs arise. With such a mindset you will start to use empathy in design.

How do you start to develop such an empathetic mindset?

In this article, Customer Experience Consultant Peter Timmer talks through what it means to design with empathy for the customer, and why it produces better products and services for pharma and healthcare.


Build a map of the customers’ environment – to better understand their experience

Empathy requires deep research with real people in their natural environments. It is deep because it will not be market research as a commodity –

"Nurse, what is your greatest frustration during therapy administration in the clinic?"
Suitable research will be grounded in getting as close to reality as possible:
  • Spending a period of time observing life in the clinic
  • Actively working with healthcare professionals (HCPs) to simulate the things which cannot be observed, maybe for reasons of confidentiality
  • Talking through scenario-based stories, stories built around models and sketches of the clinic with actors in specific places at particular times.

These are provocative methods, methods that generate data about the movements, thoughts, reasoning and emotions of the customer; methods that generate data – the value of which is unknown when a concept brief is written. Such data will help a design team know the customer better, and enable designers make better informed design decisions.

Building the map is foundational for the identification of opportunity that leads to the creation of products and services that have wider commercial value.




Download the full article from Blue Latitude Health

31st May 2016

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.
Blue Latitude Health
Creative problem solving, solved
Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.
Blue Latitude Health
Three strategies for managing loss of exclusivity successfully
Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
Blue Latitude Health
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Blue Latitude Health
Diagnosing the lag in neuropsychiatric treatments
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.
Blue Latitude Health